Torrent Pharmaceuticals Adjusts Evaluation Amid Strong Performance and Market Trends
Torrent Pharmaceuticals has recently experienced a score revision, influenced by various performance metrics. The company showcases strong management efficiency with a high Return on Capital Employed and a low Debt to EBITDA ratio. Despite consistent operational results, the stock's technical trend indicates sideways movement, reflecting mixed market dynamics.
Torrent Pharmaceuticals has recently undergone an evaluation adjustment, reflecting a revision in its score. This change is attributed to various underlying trends and metrics that highlight the company's current market position and performance indicators.The company has demonstrated a strong management efficiency, evidenced by a high Return on Capital Employed (ROCE) of 22.08%. Additionally, Torrent Pharmaceuticals maintains a low Debt to EBITDA ratio of 1.15 times, indicating a solid ability to service its debt obligations. The firm has reported positive results for six consecutive quarters, showcasing consistent operational performance.
Despite these strengths, the technical trend for the stock has shifted to a sideways movement, suggesting a lack of clear price momentum. The stock has also shown a robust return over the past year, outperforming the BSE 500 index, with a notable 25.39% return. However, long-term growth appears limited, with net sales increasing at an annual rate of 7.66% over the last five years.
Overall, the evaluation adjustment reflects a nuanced view of Torrent Pharmaceuticals' performance, balancing its strong operational metrics against the backdrop of market trends.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
